In addition to the role of PD-1/PD-1ligands in downregulation of immune responses (Figure 1), tumor cell intrinsic PD-L1 was found to support tumor-initiating cells that are known to be resistant to conventional anti-tumor drugs and to cause a relapse of tumor [89]. Here, CD274 is linked to neoplasm.